<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>CatsWannaBeCats.Com | Womble Lohmann | Activity</title>
	<link>https://www.catswannabecats.com/members/mommanx1/activity/</link>
	<atom:link href="https://www.catswannabecats.com/members/mommanx1/activity/feed/" rel="self" type="application/rss+xml" />
	<description>Activity feed for Womble Lohmann.</description>
	<lastBuildDate>Sun, 28 Jun 2026 07:29:42 -0400</lastBuildDate>
	<generator>https://buddypress.org/?v=7.2.0</generator>
	<language>en-CA</language>
	<ttl>30</ttl>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>2</sy:updateFrequency>
	
						<item>
				<guid isPermaLink="false">1a2fb3d24ff891b3259559354c62433e</guid>
				<title>Womble Lohmann posted an update: MRA prescription was not retained in the model. In [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/23986/</link>
				<pubDate>Sun, 08 Jun 2025 11:05:06 -0400</pubDate>

									<content:encoded><![CDATA[<p>MRA prescription was not retained in the model. In multivariable analyses, HK at baseline was independently associated with MRA non-prescription at baseline and subsequent discontinuation. <a href="https://www.selleckchem.com/products/rimiducid-ap1903.html" rel="nofollow ugc">selleck chemical</a> When considering subsequent discontinuation of RAASi (instead of baseline use), HK was no longer found associated with all-cause deaths.&hellip;<span class="activity-read-more" id="activity-read-more-23986"><a href="https://www.catswannabecats.com/activity/p/23986/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">4e7ac84d29c48f87e7805d31684ef8d9</guid>
				<title>Womble Lohmann posted an update: This indicated that FL-BsAb1/17 can inhibit the development [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20889/</link>
				<pubDate>Fri, 06 Jun 2025 11:59:48 -0400</pubDate>

									<content:encoded><![CDATA[<p>This indicated that FL-BsAb1/17 can inhibit the development of fibrosis by inhibiting the TGF-β/Smad2/3 signaling pathway. FL-BsAb1/17 (10 mg/kg, 5 mg/kg) could also effectively reduce the content of MDA, increase the activity of SOD and CAT, and improve the total antioxidant capacity (T-AOC). In conclusion, FL-BsAb1/17 alleviated BLM-induced SSc&hellip;<span class="activity-read-more" id="activity-read-more-20889"><a href="https://www.catswannabecats.com/activity/p/20889/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">eea483ada5576f37eaf1863b8f6917be</guid>
				<title>Womble Lohmann posted an update: These translated to a median hazard ratio of 1.36 for [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/20129/</link>
				<pubDate>Thu, 05 Jun 2025 11:24:09 -0400</pubDate>

									<content:encoded><![CDATA[<p>These translated to a median hazard ratio of 1.36 for mortality and 1.34 of graft loss for similar candidates at different centers. Post-ILDKT outcomes were not associated with the following center-level characteristics ILDKT volume and transplanting a higher proportion of highly sensitized, prior transplant, preemptive, or minority candidates.&hellip;<span class="activity-read-more" id="activity-read-more-20129"><a href="https://www.catswannabecats.com/activity/p/20129/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">f58a9bbb7b78d8d51c7b541ba0c75bda</guid>
				<title>Womble Lohmann posted an update: Chronic myelomonocytic leukemia (CMML) is defined by [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/12569/</link>
				<pubDate>Sun, 01 Jun 2025 11:11:27 -0400</pubDate>

									<content:encoded><![CDATA[<p>Chronic myelomonocytic leukemia (CMML) is defined by myelodysplasia, pathologic accumulation of monocytes and a substantial risk to transform to secondary acute myeloid leukemia (sAML). In recent years, minimal diagnostic criteria for classical CMML and CMML-variants were proposed. Moreover, potential pre-stages of CMML and interface conditions&hellip;<span class="activity-read-more" id="activity-read-more-12569"><a href="https://www.catswannabecats.com/activity/p/12569/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">b910abf59bd5cb2768c9477d81110db7</guid>
				<title>Womble Lohmann posted an update: Chemical investigation into the stems of the medicinal plant [&#133;]</title>
				<link>https://www.catswannabecats.com/activity/p/5448/</link>
				<pubDate>Sat, 31 May 2025 14:53:16 -0400</pubDate>

									<content:encoded><![CDATA[<p>Chemical investigation into the stems of the medicinal plant Schisandra sphaerandra led to the isolation and identification of a new dibenzocyclooctadiene lignan sphaerandrin A (1) and 11 known ones gomisin B (2), schirubrisin B (3), kadsuphilin B (4), schizandrin (5), benzoylgomisin Q (6), angeloylgomisin Q (7), gomisin G (8), schisanwilsonin O&hellip;<span class="activity-read-more" id="activity-read-more-5448"><a href="https://www.catswannabecats.com/activity/p/5448/" rel="nofollow ugc">[Read more]</a></span></p>
]]></content:encoded>
				
									<slash:comments>0</slash:comments>
				
							</item>
					<item>
				<guid isPermaLink="false">50328e966972c63bba5a25bac8487034</guid>
				<title>Womble Lohmann became a registered member</title>
				<link>https://www.catswannabecats.com/activity/p/5100/</link>
				<pubDate>Sat, 31 May 2025 14:28:18 -0400</pubDate>

				
									<slash:comments>0</slash:comments>
				
							</item>
		
	</channel>
</rss>